Hello, Fool! | Login | Signup | My Fool
Oct 13, 2008 4:39 PM ET | Feedback | Site Changes | Help
A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.
View All Commentary (CELG)
Recs
ypcheng (87.50) Submitted: 2/25/08 10:34 AM : Start Price: $56.09 CELG Score: 9.74
In light of the approval of Avastin by FDA to Genetech, I believe this company will gets its approvals of its rich pipeline and its stock should go up.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK